Utvikling av nye treningsmetoder I kampen mot overvekt – samarbeidsprosjekt mellom NTNU og Senter for sykelig overvekt
- Prosjektnummer
- 46013400
- Ansvarlig person
- Tomas Stølen
- Institusjon
- NTNU, ISB
- Prosjektkategori
- Phd-stipend 2006
- Helsekategori
- Cardiovascular
- Forskningsaktivitet
- 5. Treatment Developement
Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy.
Circ Res 2009 Sep;105(6):527-36. Epub 2009 aug 13
PMID: 19679837
Transcriptional changes in blood after aerobic interval training in patients with the metabolic syndrome.
Eur J Cardiovasc Prev Rehabil 2009 Feb;16(1):47-52.
PMID: 19169141
Endothelial dysfunction induced by post-prandial lipemia: complete protection afforded by high-intensity aerobic interval exercise.
J Am Coll Cardiol 2009 Jan;53(2):200-6.
PMID: 19130989
Effects of preterm birth and fetal growth retardation on cardiovascular risk factors in young adulthood.
Early Hum Dev 2009 Apr;85(4):239-45. Epub 2008 nov 13
PMID: 19013031
Aerobic interval training reduces cardiovascular risk factors more than a multitreatment approach in overweight adolescents.
Clin Sci (Lond) 2009 Feb;116(4):317-26.
PMID: 18673303
Both aerobic endurance and strength training programmes improve cardiovascular health in obese adults.
Clin Sci (Lond) 2008 Nov;115(9):283-93.
PMID: 18338980
Endurance Training Ablates Excessive SR Ca2+ Leak and Restore Impaired Ca2+- cycling in Cardiomyocytes From CaMKIIdC Overexpress
doktorgrad
Aerobic interval training abolishes the increased arrhythmia probability and restores cardiomyocyte contractility, Ca2+ cycling
doktorgrad
Depressed contractile function is linked to reduced intracellular and sarcoplasmic reticulum Ca2+ cycling and reduced transverse
doktorgrad
Impaired calcium handling in animal and human cardiomyocytes reduces contractility and increases arrhythmia potential
- Disputert:
- juni 2010
- Hovedveileder:
- Ulrik Wisløff
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU